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Objective. To obtain a psychosocial profile of patients with poststroke fatigue (PSF), which could aid in optimizing treatment
strategies. Methods. Eighty-eight outpatients with severe PSF measured with the Checklist Individual Strength-fatigue subscale
(CIS-f) and the Fatigue Severity Scale (FSS) were selected. Depression and anxiety, psychological distress, coping, social support,
and self-eﬃcacy of this group were compared to reference groups of healthy controls and patients with other chronic diseases.
Associations between psychosocial characteristics and fatigue were calculated. Results. Compared to healthy controls, patients
with PSF reported more psychological distress, less problem-focused coping, and more positive social support. Minor or no
diﬀerences were found in comparison with other chronic patients. The CIS-f correlated with somatic complaints and the FSS
with cognitive complaints. Conclusion. Patients with PSF show a psychosocial profile comparable to patients with other chronic
disease. Implications for diagnosis and treatment are discussed.
1. Introduction
In recent years, researchers have become increasingly inter-
ested in one of the most common and persisting complaints
after stroke, that is, poststroke fatigue (PSF). PSF is best
described as a feeling of early exhaustion with weariness,
lack of energy and aversion to eﬀort [1] that develops during
physical or mental activity and is usually not ameliorated by
rest [2, 3]. The percentages of patients reporting fatigue after
stroke range from 38% to 77% [4], and these percentages do
not seem to decline in the chronic stage [4–6]. Furthermore,
PSF appears to be related to highermortality rates and poorer
rehabilitation outcomes [7]. However, the pathogenesis of
PSF is still poorly understood and, until now, eﬀective
treatments are still lacking [4, 8].
Although the mechanisms leading to PSF are still elusive,
its origin is believed to be multifactorial [4]. PSF may be a
direct result of organic brain damage [9], as it has often been
reported in other types of brain disease, such as traumatic
brain injury [10]. However, only a few associations of fatigue
with biological markers have been reported in the stroke
population [4]. In other words, although stroke severity may
play a role, there is little evidence linking lesion size or
location to PSF [3–5, 11]. The origin of PSF could also be
related to psychosocial factors, which has been the focus
of numerous studies (see Lerdal et al., 2009, [4] for an
overview). Of all psychosocial factors, the most investigated
are depression, anxiety, coping skills, social support, and self-
eﬃcacy. Nevertheless, also in this area, unequivocal findings
are scarce [4].
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Because fatigue is generally considered as a symptom
of depression, an overlap between both phenomena seems
undeniable [1, 4, 9]. Indeed, an association between fatigue
and depressive symptoms is a consistent finding in the
literature not only in stroke patients [2, 5–7, 11–14], but
also in patients with traumatic brain injury [10] and in
otherwise healthy subjects [10, 13]. Yet, in those studies that
specifically looked at patients who suﬀer from depressive
symptoms and/or fatigue, a clear dissociation between the
two phenomena was also present with groups of patients
reporting just fatigue or just depression [5, 6, 11, 15].
The same seems to be true for anxiety [7]. The studies
that have examined coping style, self-eﬃcacy, and social
support suggest that emotion-oriented coping [2, 16], locus
of control directed to powerful others [5], and lack of social
support [4] are also associated with PSF. These studies
are, however, few in number and cross-sectional in design
and did not specifically focus on patients for rehabilitation
purposes. As a result, the nature of the psychosocial profile
of patients suﬀering from PSF is still largely unknown,
providing only scant clues for optimizing the treatment of
PSF [4, 8].
The aim of this study was to compare a psychological
and social profile of stroke patients, with severe PSF selected
for rehabilitation, to the one of healthy control subjects
and patients with other chronic diseases and to investigate
the strength of the association between fatigue and several
psychosocial variables. Knowledge about this psychosocial
profile can help to optimize PSF treatment.
2. Methods
2.1. Subjects. Data were gathered from patients with PSF
who participated in a larger multicenter study (COGRAT:
Eﬀectiveness of Cognitive and Graded Activity Training on
PSF [17]). In this study, 231 patients were recruited via their
treating physicians and psychologists (n = 64), through
an article about the COGRAT study in various newspapers
(n = 151), or based on their consent for renewed contact
given in earlier studies (n = 16). The study was approved by
the local ethics committee and all eligible subjects signed an
informed consent.
For the COGRAT study outpatients in the chronic stage
of stroke (at least 4 months after stroke) were identified
according to the following criteria: (1) age between 18
and 70; (2) last stroke episode longer than 4 months ago
(either cerebral infarction, or intracerebral or subarachnoid
hemorrhage; single or recurrent stroke); (3) severe fatigue
(Checklist Individual Strength 20R-Fatigue subscale [18]
≥ 40); (4) ability to walk independently. Patients were
excluded from the study if they had (1) severe visual
hemineglect, Behavioural Inattention Test ≤ 129 [19], (2)
severe memory deficits (Rivermead Behavioural Memory
Test [19] screening score < 8), (3) executive impairments
(Behavioural Assessment of the Dysexecutive Syndrome [19]
< borderline), (4) moderate to severe aphasia (Token Task
[19] >12), (5) severe cardiac or pulmonary disease, or (6) co-
morbid depression (Hospital Anxiety and Depression Scale
depression scale > 10). If the HADS depression scale score
was between 8 and 10, a clinical interview (MINI DSM-
IV [20]) was conducted to exclude patients with clinical
depression.
Of the 124 excluded patients, 47 (54%) were not severely
fatigued and 21 had too high levels of depression. The
remaining 56 patients met one or more other exclusion
criteria, such as memory deficits, mobility deficits, or
aphasia. Nineteen more patients withdrew their consent
before completion of assessment. Thus, 88 patients (38%)
were finally included. These participants did not diﬀer
significantly with regard to age and gender (alpha = 0.05)
from the nonparticipants and those excluded based on too
high levels of depression.
2.2. Demographic and Clinical Assessment. Data on age, sex,
marital status, educational level, and stroke type and side
were obtained from the patients and their medical records.
Severity of paresis was assessed with theMotricity Index (MI)
of the aﬀected lower extremity [21]. The MI was recorded
because lower extremity paresis is strongly related to balance
[22] and mobility after stroke [23], and mobility might be
associated with poststroke depression [24].
2.3. Assessment of Fatigue. Two widely used and well-
validated measures of fatigue were used in this study, the
subscale fatigue of the Checklist Individual Strength 20R
(CIS-f) [18] and the Fatigue Severity Scale (FSS) [25]. The
CIS-f consists of 8 out of 20 items of the questionnaire,
asking about fatigue severity in the two weeks before the
assessment, to be indicated on a 7-point Likert scale (range
8–56). Patients with a score≥40 on this subscale were defined
as being severely fatigued [6]. In the FSS, individuals rate
their agreement with nine statements on a 7-point Likert
scale concerning fatigue severity, frequency, and impact on
daily life. The mean score (range 1–7) is then calculated. The
threshold for moderate to high impact of fatigue using the
FSS is commonly set at either 4 or 5 [26].
2.4. Psychosocial Assessment. To study the psychosocial char-
acteristics of patients with PSF, self-report questionnaires
regarding depression, anxiety, psychological distress, coping,
social support, and self-eﬃcacy were used. Depression and
anxiety were measured with the Hospital Anxiety and
Depression Scale (HADS) [27]. The HADS is a 14 item
self-report measure, with seven items forming a depression
subscale and another seven constituting an anxiety subscale.
Each item is rated on a four-point scale, ranging from 0 to
3, with 3 reflecting the highest distress. Total scores for each
subscale range from 0 to 21 and are categorized as normal (0–
7), mild (8–10), moderate (11–14), or severe (15–21) [28].
The Symptom Checklist-90 (SCL) [29] measures psycho-
logical distress [30]. The scale consists of 90 items scored on
a 5-point Likert scale. Nine psychopathology scores can be
derived and the total score (GSI) reflects a global severity
index of psychological distress. Furthermore, a personality
severity index (PSI) to assess personality problems can be
calculated [31]. This is done by transferring raw scores to
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SCL-90R scales, and then comparing the mean scores of
the scales interpersonal sensitivity, hostility, and paranoid
ideation to the mean value of the remaining scales.
Coping strategies were assessed with the coping inventory
for stressful situations (CISS) [32]. Forty-eight items are
scored on a 5-point Likert scale, resulting in three sub-
scales: Problem-focused coping, Emotion-focused coping,
and Avoidance-focused coping.
Social support was assessed with the Social support list
(SSL-12) [33] that consists of twelve statements regarding
perceived positive and negative social support from the pri-
mary social network. Positive support is described by three
subscales: everyday support, support in problem situations,
and esteem support.
The Self-Eﬃcacy Scale (SES) was used to assess the sense
of control in relation to fatigue complaints [34]. It consists of
5 statements each scored on a 5-point scale. The total scores
ranges from 5 to 25, with a higher score reflecting more sense
of control.
2.5. Data Analysis. Descriptive statistics (i.e., mean and
standard deviation (SD)) were calculated for all psychosocial
characteristics. These values were compared to known
reference values and derived Z-scores from healthy controls
and patient populations (General practice, traumatic brain
injury, chronic pain, Multiple Sclerosis, Parkinson, Cancer,
Rheumathoid Arthritis, and Chronic Fatigue Syndrome)
reported in the literature [28, 29, 32, 33, 35–37]. Based on
these Z-scores diﬀerent categories were labeled as follows:
< −1.28 = very low, < −.84 = low, < −.525 = below average,
between −.525 and .525 = average, >.525 = above average,
>.84 high and >1.28 very high.
The presence of personality problems was determined by
calculating a PSI from the raw scores of the SCL. Associations
between the CIS-f-FSS fatigue scales and gender, marital
status, lesion characteristics, and PSI were calculated with
χ2 analyses. Spearmen rank correlations were calculated
with the ordinal demographical, stroke, and psychosocial
characteristics. Then a stepwise multiple regression analysis
was performed on the variables significantly associated
with fatigue to establish their unique contribution. All
data analyses were computed with SPSS version 17.0, using
Holm’s correction to adjust for multiple analyses [38].
3. Results
Demographic data, severity of paresis, fatigue scores, and
stroke characteristics are summarized in Table 1. Scores on
both fatigue scales indicated on average “severe fatigue.” On
the CIS-f, 92.0% of the subjects scored above 40. On the
FSS, 92.0% scored above 4 and 69.3% above 5. The mean MI
was 90.2 indicating on average mild lower extremity paresis.
Mean postonset time since last stroke was 4.3 years, which
did not diﬀer significantly between single and recurrent
strokes.
3.1. Psychosocial Characteristics. To investigate the psychoso-
cial characteristics of our patients, the scores were compared
Table 1: Demographic data, severity of paresis, stroke data and
fatigue scores (n = 88).
Demographics
Age, mean (SD) 54.6 (8.8)
Gender, male, no. (%) 46 (52.3%)
Living together/married, no. (%) 71 (80.7%)
Educational level, median (SD), (1 =
low to 7 = high)
5 (1.2)
Severity of paresis
Motricity Index, mean (SD) 90.2 (13.6)
Stroke
Time since last lesion, mean (SD) 4.3 (5.3)
Single Stroke, no. (%) 67 (76.1%)
Ischemic strokea, no. (%) 64 (72.7%)
Hemorrhageb, no. (%) 6 (6.82%)
Subarachnoid hemorrhage, no. (%) 9 (10.2%)
Mixedc, no. (%) 4 (4.5%)
Fatigue
CIS-f, mean (SD) 45.4 (5.6)
FSS, mean (SD) 5.2 (1.0)
CIS-f: Checklist Individual Strength subscale fatigue.
FSS: Fatigue Severity Scale.
aICVA category: 18 left hemispheric, 44 right hemispheric, 4 infratentorial,
and 3 bilateral.
bHemorrhage category: 4 right hemispheric, 2 bilaterial.
cMixed: 4 infratentorial and other lesion.
to reference values obtained from norm groups of healthy
controls and patient groups from general health practice
and with various chronic aﬄictions (Table 2). The HADS
anxiety scores were comparable to other patient groups but
high when compared to the general population. Using the
Z-score derived, abovementioned categories [28], 60.2% of
the patients had normal, 17% mild, 18.2% moderate, and
4.5% severe scores on HADS-anxiety. On the depression
subscale of the HADS, we found high scores compared to
both the general population and general practice patients.
Still, 64.8% of our subjects had normal and the remaining
35.2% only mild depressive symptoms. The scores on the
SCL were generally high compared to healthy controls, but
in comparison to other patient groups the SCL scores were
average, except for the subscale “Obsessive Compulsive”
which was above average, reflectingmore subjective cognitive
complaints. The PSI is a categorical value and could therefore
not be compared to reference values. Nevertheless, the
incidence rate indicated that 93.2% of the patients were free
from personality problems.
As for coping strategies, our patients showed slightly
lower levels of problem-focused and avoidance strategies
than healthy controls. However, in comparison to other
patient groups, they scored average or above average for all
strategies. Furthermore, our patients received more positive
social support with as many negative social interactions
compared to healthy controls and other patient groups.
Compared to patients with chronic fatigue syndrome (CFS)
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Table 2: Means and standard deviations of baseline psychosocial characteristics of PSF patients in comparison with healthy controls and
patients with other chronic disease (n = 88).
Scale at inclusion
Mean (SD)
Study group
In comparison to:
Healthy controls Patient groups
Psychosocial characteristics
HADS
General population 57–65
years (n = 1901) [35]
General practice
patients (n = 112) [35]
Traumatic brain
injury patients
(n = 100) [28]
Anxiety 7.27 (3.76) High Average Average
Depression 7.05 (2.37) High High Average
Psychological distress: SCL
Healthy controls
(n = 2092) [29]
General practice
patients (n = 920) [29]
Chronic pain
patients
(n = 2461) [29]
Anxiety 15.08 (4.84) Above average/high Average Average
Phobic anxiety 9.13 (3.06) Above average/high Average Average
Depression 27.44 (7.80) High Average Average
Somatic 22.25 (6.61) High Average Average
Obsessive-compulsive 20.51 (6.47) Very high Above average Above average
Interpersonal sensitivity 26.98 (8.95) Average Average Average
Hostility 8.36 (2.45) Average Average Average
Sleep disturbances 6.74 (3.21) Above average/high Average Average
Total (GSI) 149.00 (35.80) High Average Average
Coping styles (CISS)
Working adults (n = 683)
[32]
Multiple Sclerosis
patients (n = 96) [32]
Parkinson patients
(n = 75) [32]
Problem focused 51.89 (10.98) Low Average Above average
Emotion-oriented coping 35.75 (10.51) Average Average Above average
Avoidance 40.55 (10.66) Below average Above average Above average
Social support (SSL-12)
Healthy elderly (n = 5279)
[33]
Cancer patients
(n = 475) [36]
Rheumatoid
arthritis patients
(n = 246) [36]
Everyday support 10.69 (2.08) Above average
Support in problem situations 9.76 (2.24) High
Esteem support 10.35 (2.10) High
Negative social interactions 9.91 (2.92) Average [36] Average Average
Self-eﬃcacy (SES)
Chronic fatigue
syndrome patients
(n = 292) [37]
Self eﬃcacy 16.57 (3.32) Above average
HADS: Hospital Anxiety and Depression Scale, SCL: Symptom Checklist-90, CISS: Coping Inventory for Stressful Situations, SSL-12: Social Support List, and
SES: Self Eﬃcacy Scale.
Reference values were derived from known norm groups or research data from diﬀerent studies. From research data, means and Z-scores were calculated,
and categories were described based on Z-scores as follows: < −1.28 = very low, < −.84 = low, < −.525 = below average, between −.525 and .525 = average,
>.525 = above average, >.84 high, and >1.28 very high.
[37], they reported to be “more in control” when assessed
with the SES.
3.2. Associations of Demographic, Clinical, and Psychosocial
Characteristics with Fatigue. Table 3 shows the correlation
coeﬃcients of demographic, clinical, and psychosocial char-
acteristics with both fatigue scores. No associations with
either fatigue scale (CIS-f or FSS) were found for demo-
graphic data, stroke characteristics, or severity of paresis
(MI).
The CIS-f scale showed a statistically significant but
moderate association with SCL-somatic and SCL-depression.
The FSS was only related to the Obsessive Compulsive
subscale of the SCL. No other significant associations were
found for any psychosocial measure.
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Table 3: Correlation coeﬃcients of demographic, clinical, and
psychosocial characteristics with PSF (n = 88).
CIS-f FSS
Demographic data
Age2 n.s. n.s.
Gender1 n.s. n.s.
Marital status1 n.s. n.s.
Educational level2 n.s. n.s.
Stroke characteristics
Single or recurrent stroke1 n.s. n.s.
Lesion side of last stroke1 n.s. n.s.
Time since last stroke2 n.s. n.s.
Severity of paresis (MI)2 n.s. n.s.
Psychosocial characteristics
Anxiety and depression (HADS)2
HADS-anxiety n.s. n.s.
HADS-depression n.s. n.s.
Psychological distress (SCL)2
Anxiety n.s. n.s.
Phobic anxiety n.s. n.s.
Depression 0.35∗ n.s.
Somatic 0.53∗ n.s.
Obsessive compulsive n.s. 0.36∗
Intrapersonal sensitivity n.s. n.s.
Hostility n.s. n.s.
Sleep disturbances n.s. n.s.
Total (GSI) 0.34∗ n.s.
Personality problems (PSI)1 n.s. n.s.
Coping (CISS)2
Problem-focused coping n.s. n.s.
Emotion-oriented coping n.s. n.s.
Avoidance n.s. n.s.
Distraction seeking n.s. n.s.
Company seeking n.s. n.s.
Social support (SSL-I-N)2
Total positive support n.s. n.s.
Negative social interactions n.s. n.s.
Self-eﬃcacy (SES)2 n.s. n.s.
1χ2 analyses (categorical data)
2Spearman rank correlation coeﬃcients
n.s.: not significant
∗significant at Holm’s correction (P < .0011)
CIS-f: Checklist Individual Strength fatigue severity subscale
FSS: Fatigue Severity Scale
Multiple regression analysis was performed only for the
CIS-f with associated variables, since the FSS correlated
with just one psychosocial variable (Table 3). SCL-Som
significantly predicted CIS-f scores, β = .54, t(86) = 5.89,
P < .001. SCL-Dep did not add significantly to the model
(P = .78) with no concerns for multicolinearity (VIF = 1.56,
tolerance = .64).
4. Discussion
The aim of this investigation was to obtain a psychosocial
profile of patients suﬀering from severe PSF in order to
tease out options for the rehabilitation of fatigue. The
results of this study suggest, however, that these patients
are not characterized by a distinct psychosocial profile.
In comparison to healthy controls, PSF-patients reported
high psychosocial distress, high positive social support, and
low problem-focused coping. However, compared to other
chronic patient groups, we found no marked discrepancies
with regard to distress, coping styles, social support, and self-
eﬃcacy. Moreover, independent associations with fatigue
were only found for SCL-Somatic Complaints with CIS-f
(r = .54; P < .001) and SCL-Obsessive Compulsive with
FSS (r = .35; P < .001), but not for any other psychosocial
variable or stroke characteristic (e.g., time since stroke, single
versus recurrent, nature of lesion, and lesion side).
The subscale Obsessive Compulsive of the SCL might
mimic the direct neurological consequences of stroke, since it
includes items such as “trouble with thinking,” “mental slow-
ness,” “needing to check things” and “thinking things over.”
Although no direct association between fatigue severity and
severity of cognitive deficits has been found [4, 5, 14], a
relationship between fatigue and cognitive complaints, such
as mental slowness, has been substantiated [13, 39].
A probable cause for the experienced fatigue may be
found in this light. Cognitive deficits may temporarily be
compensated for by exerting increased mental eﬀort, which
then may cause fatigue [40]. Indeed, widespread brain
activity has been shown in patients with unilateral lesions
of one cerebral hemisphere trying to perform a unimanual
task with their aﬀected hand [41]. Such activities typically
require a great amount of attentional resources, because
subjects act at the limits of (or even beyond) their functional
capacities [42]. A parallel can be drawn from studies of
traumatic brain injury where aﬀected individuals showed
more dispersion and more brain regions activated when
engaged in an attention task than healthy controls [43,
44].
Thus, PSF might be associated with underlying cognitive
mechanisms that are independent of the extent of the
brain lesion and of psychopathological problems related or
unrelated to stroke. If this notion is valid, it would be
consistent with the finding that fatigue is almost as frequent
in relatively mildly aﬀected patients as in the more severely
aﬀected ones [4, 5], because it will become a problem
whenever subjects try to overcome their individual subtle or
severe limits. As soon as subjects are able to deal with their
functional limitations more eﬀectively, taking into account
their limited attentional capacity and mental energy, fatigue
may gradually become less severe.
The association between fatigue and somatic complaints
could also be seen in line with this hypothesis. Somatic
complaints may reflect the direct physical consequences of
stroke, causing functional limitations and/or pain, requiring
more task-related physical and mental eﬀort and thereby
provoking fatigue. Another part of the somatic complaints
could be explained as the physical expression of fatigue. For
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example, many patients report a heavy feeling in arms and
legs, nausea, or headaches when becoming tired.
As in previous studies, we first found an association
between depression and fatigue on one of our fatigue scales
[2, 5–7, 11–14]. However, this association was subordinated
to somatic complaints in the regression analysis. A variant of
thismoderating eﬀect has been previously reported in a study
wherein the association between fatigue and depression
became weaker, when controlled for by sickness and impact
on ambulation [6]. This finding emphasizes not only the
dissociation of fatigue and depression, but also the need to
assess physical complaints in depth.
A rather unexpected but noteworthy finding of this study
was that both fatigue measurements used, the FSS and CIS-f,
were associated with completely diﬀerent variables as shown
in Table 3. The use of more than one fatigue scale in clinical
practice and research might therefore be warranted.
This study holds several limitations. Due to its cross-
sectional design we are unable to infer causal relationships.
Furthermore, our inclusion criteria restricted the variability
of fatigue and mobility, thereby possibly lowering associa-
tions. The exclusion of patients with severe cognitive deficits,
depression and motor problems might be considered both a
strength and a limitation of this study. The major limitation
is that it precludes generalization to other stroke patients.
On the other hand, this choice enabled us to single out
the relationship between fatigue and psychosocial factors,
without the influence of these confounding factors.
5. Conclusions and Implications for Treatment
By comparing our study group to other reference groups, PSF
patients displayed a “normal chronic patient” psychosocial
profile. Only cognitive and somatic complaints were associ-
ated directly with fatigue. We therefore propose that (a part
of) the fatigue might be a consequence of the inadequate
adaptation to diminished and or less eﬃcient attentional
resources after stroke.
Our findings suggest the following implications for
treatment. Somatic complaints should be directly addressed,
whenever possible. Graded physical activity programs might
be an important contribution to the treatment of PSF, since
exercise has been found to be helpful in improving physical
and functional outcomes and to reduce fatigue in various
other medical conditions [45, 46]. Such programsmight help
stroke patients to gradually increase physical activity without
experiencing distressing bodily symptoms.
Second, cognitive compensation strategies circumvent-
ing the limited energetic resources available to patients
suﬀering from PSF might also be beneficial. These com-
pensation strategies could entail an enhanced planning and
variation of activities to foster a more regular pattern of
activity and rest [14]. Here, patient education and goal
setting could be added to improve patient motivation and
adherence [47].
Third, since symptoms of depression and anxiety are
common in PSF patients, it is important to address these
when present, since they may compromise self-management
[48]. An augmented form of cognitive behavioral therapy, as
proposed by Broomfield et al., 2010, [49], is a good starting
point to address these issues. It takes into account cognitive
deficits and grievance of loss of abilities and could also aid
in implementing the behavioral changes needed to apply
compensation strategies. Lastly, our results point to the use
of more than one scale to assess PSF, highlighting that fatigue
is not only a common but also a complex and multifaceted
syndrome.
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